Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Preti, M; Lewis, F; Carcopino, X; Bevilacqua, F; Ellis, LB; Halonen, P; Hemida, R; Jach, R; Kesic, V; Kyrgiou, M; Maggino, T; Pedro, A; Querleu, D; Stockdale, C; Taumberger, N; Temiz, BE; Vieira-Baptista, P; Gultekin, M.
Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) consensus statements.
Int J Gynecol Cancer. 2025; 35(1): 100007
Doi: 10.1016/j.ijgc.2024.100007
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Taumberger Nadja
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Vulvar squamous cell carcinoma incidence is increasing, especially among women under 60, largely attributed to human papillomavirus infections. Precursor pre-invasive vulvar lesions are frequently underdiagnosed. Routine vulvar inspection during cervical cancer screening could offer an opportunity for the detection of these lesions. OBJECTIVE: To emphasize the importance of integrating routine vulvar inspection during cervical cancer screening procedures and to raise awareness about the early detection of vulvar squamous cell carcinoma and its precursors to reduce the diagnostic delay of vulvar pathologies. METHODS: A multidisciplinary task force comprising experts from 4 international scientific societies was formed. A focused literature review was conducted, and consensus statements were developed through a structured voting process to ensure clinical relevance and comprehensiveness. RESULTS: The consensus defines key elements of normal vulvar anatomy, identifies potential pre-cancerous dermatoses, and highlights risk factors for vulvar malignancy. The consensus statements promote the integration of vulvar inspection into cervical cancer screening procedures, urging health care professionals across various levels to receive training and guidance in vulvar examinations and enhancing patient education. Health care providers are recommended to gather a brief history of vulvar symptoms, conduct comprehensive inspections of the vulvar area, and report any abnormalities. For patients with positive human papillomavirus or Pap tests, they should closely monitor vulvar findings, encourage self-examinations, and discuss risks for intra-epithelial or invasive neoplasia. CONCLUSIONS: Establishing standardized practices in vulvar inspection during cervical cancer screening procedures along with public awareness, could significantly impact early detection and timely interventions of vulvar pathologies at cancer risk ultimately reducing the burden of vulvar cancers.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Female - administration & dosage
- Uterine Cervical Neoplasms - diagnosis, pathology
- Vulvar Neoplasms - diagnosis, pathology
- Early Detection of Cancer - methods, standards
- Carcinoma, Squamous Cell - diagnosis, pathology
- Vulva - pathology
- Europe - administration & dosage
- Societies, Medical - standards
- Consensus - administration & dosage
- Colposcopy - standards, methods
- Find related publications in this database (Keywords)
- Vulvar inspection
- Cervical cancer screening
- Vulvar cancer
- Awareness
- Healthcare providers